McCoy v. Calamia

653 So. 2d 763, 94 La.App. 3 Cir. 1274, 1995 La. App. LEXIS 852, 1995 WL 144815
CourtLouisiana Court of Appeal
DecidedApril 5, 1995
DocketNo. 94-1274
StatusPublished
Cited by3 cases

This text of 653 So. 2d 763 (McCoy v. Calamia) is published on Counsel Stack Legal Research, covering Louisiana Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
McCoy v. Calamia, 653 So. 2d 763, 94 La.App. 3 Cir. 1274, 1995 La. App. LEXIS 852, 1995 WL 144815 (La. Ct. App. 1995).

Opinions

JiDOUCET, Chief Judge.

This is an appeal from a jury verdict finding that Dr. James Lipstate did not commit malpractice in his treatment of Mrs. Janell McCoy.

In late 1984, Mrs. McCoy was diagnosed as having rheumatoid arthritis. Rheumatoid arthritis is disease of the joint. The synovi-um or lining of the joint becomes inflamed and can eat into the bone. The inflammation produces an excess of fluid. The fluid so produced is abnormal in that it does not have lubricating quality of normal synovial fluid found around the joints. Symptoms of rheumatoid arthritis include joint pain, swelling [765]*765and deformity of the joints. Dr. James Cala-mia treated Mrs. McCoy from her diagnosis until March 1, 1990, when he moved his practice. On her initial visit her blood pressure was 106/70. Dr. Calamia initially prescribed Naprosyn, a non-steroidal anti-inflammatory drug and Ridaura, a drug containing gold that helps relieve the symptoms of rheumatoid arthritis by unknown means. She continued to take Naprosyn until May 1990. In July 1989, the Ridaura was discontinued because it was losing effect. Metho-trexate was |2prescribed in its place. She began taking 7.5 mg. of methotrexate per week, orally. Between October 1984 and July 1989 Mrs. McCoy’s blood pressure varied from a low of 102/64 to a high of 120/80. In September 1989 her blood pressure reading went up to 170/90. In December 1989, Dr. Lipstate saw Mrs. McCoy in Dr. Cala-mia’s place. She was having a severe flare up of her arthritis with symptoms of carpal tunnel syndrome caused by the swelling. Her blood pressure was 140/84. Dr. Lipstate increased the methotrexate to 10 mg. per week. He prescribed folic acid. Folic acid tends to decrease such side effects of metho-trexate as nausea, hair loss and mouth lesions. He also gave her an injection of Me-thylprednisolone, a steroid that rapidly reduces swelling. On March 1,1990, Dr. Lips-tate took over the treatment of Mrs. McCoy. On that date he increased the dosage of the methotrexate to 15 mg. per week. Her blood pressure was 182/90. In May 1990, Dr. Lips-tate discontinued the Naprosyn and began giving Mrs. McCoy Voltaren, another non-steroidal anti-inflammatory drug. Her blood pressure was 152/74 on that visit. On August 15, 1990, Dr. Lipstate injected Mrs. McCoy with 15 mg. of methotrexate. Her blood pressure was 136/82.

On August 18, 1990, Mrs. McCoy suffered a stroke. As a result Mrs. McCoy and her husband made medical malpractice claims against Drs. Calamia and Lipstate alleging that their negligence in treating her was the cause of her stroke. The claim was first submitted to a medical review board. The medical review board found that:

“1.
The evidence does not support the conclusion that the defendant, JAMES LIPS-TATE, M.D., failed to meet the applicable standard of care as charged in the complaint.
2.
The conduct complained of was not a factor of any resultant damages to plaintiff.”

Dr. Calamia was dismissed from the suit prior to trial. Before trial the plaintiffs were ordered to comply with Fifteenth Judicial District local rule 17 which required them to deposit with the court reporter the cost of taking the trial testimony.

After trial, the jury rendered a verdict in which it found that Dr. Lipstate did not lack that degree of knowledge and skill required by national standards of practice for the 13medical specialty of rheumatology. The jury further found that Dr. Lipstate’s conduct did not fall below the standard of care required of him as a rheumatologist under the circumstances. The trial judge assessed costs pursuant to a motion filed by the defendant. The plaintiffs filed a post-trial motion for contempt against Dr. Hector Mena for failure to attend the trial. The plaintiffs then filed a motion to recuse the trial judge. The trial judge denied the motion for contempt after refusing to deal with the motion to recuse because no order was attached to it. The plaintiffs appeal the verdict, and the refusal of trial judge to assign the motion for recusal to another judge before hearing the motion for contempt and the order requiring them to comply with local rule 17.

The plaintiffs allege that the jury verdict was tainted by legal errors made by the trial judge to such an extent that the verdict is invalid. They argue that, as a result, they are entitled to a de novo review by this court. COMMENTS ON THE EVIDENCE

The plaintiffs first allege that the trial judge erred by commenting on the evidence. The alleged comment occurred during the cross-examination of the defendant, Dr. Lips-tate, by counsel for plaintiff. Counsel was questioning the defendant about the drug [766]*766Naprosyn. Counsel for the defendant objected to the relevancy of the line of questioning. During the argument on the objection the trial judge made the following exchange took place:

THE COURT: Well, the problem is you’ve carried this discussion on Naprosyn a little too far, and I think we need to move on. Okay?
MR. SIMON: Well, we’re talking about the generator of the system, Your Honor.
THE COURT: I understand, Mr. Simon. What you’re doing is giving us all an anatomy class that I’m not sure anybody is following now, and I think that—
MR. SIMON: Well, I object to that. I object to Your Honor’s comment. This is for the jury to determine, if Your Honor please. As long as I’m engaged in relevant examination, it’s for the jury to determine what the impact of that testimony is.
THE COURT: I agree one hundred percent, Mr. Simon,—
MR. SIMON: Yes, sir.
UTHE COURT: —but the problem is the doctor’s giving you answers that you’re not satisfied with, and you’re now arguing with him.
MR. SIMON: I’m not arguing.
THE COURT: And I think that’s what we’re doing. Okay....

The plaintiffs argue that the trial judge’s “characterization of plaintiffs’ counsel’s examination of the defendant as a boring anatomy class no one wants to listen to was both improper and highly prejudicial” and requires reversal of the jury verdict.

La.C.C.P. art. 1791 states that:

“The judge in the presence of the jury shall not comment upon the facts of the case, either by commenting upon or recapitulating the evidence, repeating the testimony of any witness, or giving an opinion as to what has been proved, not proved, or refuted.”

In the recent case of Dixon v. Winn-Dixie Louisiana, Inc., 93-1627 (La.App. 4 Cir. 5/17/94), 638 So.2d 306, 312, the court discussed this as follows:

“Generally, a trial judge is afforded discretion in conducting a trial, even a jury trial. However, that discretion is circumscribed by considerations of justice and fairness and by La.C.C.P. art. 1791, which prohibits a trial judge from making any kind of comments on the evidence. The trial judge is generally prohibited from engaging in a pattern of judicial conduct which demonstrates prejudice to one party and/or partiality to the other party.”

This court in Calhoun v. Federated Rural Elec. Ins. Co., 571 So.2d 672, 677 (La.App. 3 Cir.1990), writ denied, 577 So.2d 14 (La.1991) also discussed this subject:

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Yates v. University of West Virginia Board of Trustees
549 S.E.2d 681 (West Virginia Supreme Court, 2001)
Lege v. Abbeville City Council
787 So. 2d 1228 (Louisiana Court of Appeal, 2001)

Cite This Page — Counsel Stack

Bluebook (online)
653 So. 2d 763, 94 La.App. 3 Cir. 1274, 1995 La. App. LEXIS 852, 1995 WL 144815, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mccoy-v-calamia-lactapp-1995.